These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 36066271)

  • 1. Index of microcirculatory resistance in the assessment of coronary microvascular dysfunction in hypertrophic cardiomyopathy.
    Aguiar Rosa S; Mota Carmo M; Rocha Lopes L; Oliveira E; Thomas B; Baquero L; Cruz Ferreira R; Fiarresga A
    Rev Port Cardiol; 2022 Sep; 41(9):761-767. PubMed ID: 36066271
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diagnosis of Microvascular Angina Using Cardiac Magnetic Resonance.
    Liu A; Wijesurendra RS; Liu JM; Forfar JC; Channon KM; Jerosch-Herold M; Piechnik SK; Neubauer S; Kharbanda RK; Ferreira VM
    J Am Coll Cardiol; 2018 Mar; 71(9):969-979. PubMed ID: 29495996
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Coronary microvascular dysfunction in Takotsubo syndrome and associations with left ventricular function.
    Ekenbäck C; Nickander J; Jokhaji F; Tornvall P; Engblom H; Spaak J; Persson J
    ESC Heart Fail; 2023 Aug; 10(4):2395-2405. PubMed ID: 37218383
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Automated Pixel-Wise Quantitative Myocardial Perfusion Mapping by CMR to Detect Obstructive Coronary Artery Disease and Coronary Microvascular Dysfunction: Validation Against Invasive Coronary Physiology.
    Kotecha T; Martinez-Naharro A; Boldrini M; Knight D; Hawkins P; Kalra S; Patel D; Coghlan G; Moon J; Plein S; Lockie T; Rakhit R; Patel N; Xue H; Kellman P; Fontana M
    JACC Cardiovasc Imaging; 2019 Oct; 12(10):1958-1969. PubMed ID: 30772231
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 3.0 T magnetic resonance myocardial perfusion imaging for semi-quantitative evaluation of coronary microvascular dysfunction in hypertrophic cardiomyopathy.
    Yin L; Xu HY; Zheng SS; Zhu Y; Xiao JX; Zhou W; Yu SS; Gong LG
    Int J Cardiovasc Imaging; 2017 Dec; 33(12):1949-1959. PubMed ID: 28612277
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Invasive assessment of coronary microvascular dysfunction in hypertrophic cardiomyopathy: the index of microvascular resistance.
    Gutiérrez-Barrios A; Camacho-Jurado F; Díaz-Retamino E; Gamaza-Chulián S; Agarrado-Luna A; Oneto-Otero J; Del Rio-Lechuga A; Benezet-Mazuecos J
    Cardiovasc Revasc Med; 2015; 16(7):426-8. PubMed ID: 26235975
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diagnostic value of the novel CMR parameter "myocardial transit-time" (MyoTT) for the assessment of microvascular changes in cardiac amyloidosis and hypertrophic cardiomyopathy.
    Chatzantonis G; Bietenbeck M; Florian A; Meier C; Stalling P; Korthals D; Reinecke H; Yilmaz A
    Clin Res Cardiol; 2021 Jan; 110(1):136-145. PubMed ID: 32372287
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gadolinium-Free Cardiac MR Stress T1-Mapping to Distinguish Epicardial From Microvascular Coronary Disease.
    Liu A; Wijesurendra RS; Liu JM; Greiser A; Jerosch-Herold M; Forfar JC; Channon KM; Piechnik SK; Neubauer S; Kharbanda RK; Ferreira VM
    J Am Coll Cardiol; 2018 Mar; 71(9):957-968. PubMed ID: 29495995
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Associations between perfusion defects, tissue changes and myocardial deformation in hypertrophic cardiomyopathy, uncovered by a cardiac magnetic resonance segmental analysis.
    Garcia Brás P; Aguiar Rosa S; Thomas B; Fiarresga A; Cardoso I; Pereira R; Branco G; Cruz I; Baquero L; Cruz Ferreira R; Mota Carmo M; Rocha Lopes L
    Rev Port Cardiol; 2022 Jul; 41(7):559-568. PubMed ID: 36065775
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Coronary Microvascular Dysfunction Assessed by Pressure Wire and CMR After STEMI Predicts Long-Term Outcomes.
    Scarsini R; Shanmuganathan M; De Maria GL; Borlotti A; Kotronias RA; Burrage MK; Terentes-Printzios D; Langrish J; Lucking A; Fahrni G; Cuculi F; Ribichini F; Choudhury RP; Kharbanda R; Ferreira VM; Channon KM; Banning AP;
    JACC Cardiovasc Imaging; 2021 Oct; 14(10):1948-1959. PubMed ID: 33865789
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Invasive Assessment of Microvascular Resistance in Hypertrophic Cardiomyopathy With Echocardiographic Correlates.
    Bakar SN; Hayman S; McCarty D; Thain AP; McLellan A; Wagner C; Lavi S
    Heart Lung Circ; 2022 Feb; 31(2):194-198. PubMed ID: 34332889
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Three-Vessel Assessment of Coronary Microvascular Dysfunction in Patients With Clinical Suspicion of Ischemia: Prospective Observational Study With the Index of Microcirculatory Resistance.
    Kobayashi Y; Lee JM; Fearon WF; Lee JH; Nishi T; Choi DH; Zimmermann FM; Jung JH; Lee HJ; Doh JH; Nam CW; Shin ES; Koo BK
    Circ Cardiovasc Interv; 2017 Nov; 10(11):. PubMed ID: 29146670
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quantitative diffusion-weighted magnetic resonance imaging in the assessment of myocardial fibrosis in hypertrophic cardiomyopathy compared with T1 mapping.
    Wu LM; Chen BH; Yao QY; Ou YR; Wu R; Jiang M; Hu J; An DA; Xu JR
    Int J Cardiovasc Imaging; 2016 Aug; 32(8):1289-97. PubMed ID: 27198892
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relation of Thrombolysis in Myocardial Infarction Frame Count to Invasively Measured Coronary Physiologic Indexes.
    Yamazaki T; Saito Y; Yamashita D; Kitahara H; Kobayashi Y
    Am J Cardiol; 2024 Jan; 211():282-286. PubMed ID: 37980999
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of Sex Differences on Invasive Measures of Coronary Microvascular Dysfunction in Patients With Angina in the Absence of Obstructive Coronary Artery Disease.
    Kobayashi Y; Fearon WF; Honda Y; Tanaka S; Pargaonkar V; Fitzgerald PJ; Lee DP; Stefanick M; Yeung AC; Tremmel JA
    JACC Cardiovasc Interv; 2015 Sep; 8(11):1433-1441. PubMed ID: 26404195
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Angiographic Coronary Slow Flow Is Not a Valid Surrogate for Invasively Diagnosed Coronary Microvascular Dysfunction.
    Mayer M; Allan T; Harkin KL; Loftspring E; Saffari SE; Reynolds HR; Paul J; Kalathiya R; Shah AP; Nathan S; McCarthy MC; Smilowitz NR; Miner SES; Blair J
    JACC Cardiovasc Interv; 2024 Apr; 17(7):920-929. PubMed ID: 38599696
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Impact of Ischemia Assessed by Magnetic Resonance on Functional, Arrhythmic, and Imaging Features of Hypertrophic Cardiomyopathy.
    Aguiar Rosa S; Thomas B; Fiarresga A; Papoila AL; Alves M; Pereira R; Branco G; Cruz I; Rio P; Baquero L; Ferreira RC; Mota Carmo M; Lopes LR
    Front Cardiovasc Med; 2021; 8():761860. PubMed ID: 34977179
    [No Abstract]   [Full Text] [Related]  

  • 18. Implementation of Microcirculation Examination in Clinical Practice-Insights from the Nationwide POL-MKW Registry.
    Januszek R; Kołtowski Ł; Tomaniak M; Wańha W; Wojakowski W; Grygier M; Siłka W; Jan Horszczaruk G; Czarniak B; Kręcki R; Guzik B; Legutko J; Pawłowski T; Wnęk P; Roik M; Sławek-Szmyt S; Jaguszewski M; Roleder T; Dziarmaga M; Bartuś S
    Medicina (Kaunas); 2024 Feb; 60(2):. PubMed ID: 38399564
    [No Abstract]   [Full Text] [Related]  

  • 19. Coronary Microvascular Dysfunction.
    Vancheri F; Longo G; Vancheri S; Henein M
    J Clin Med; 2020 Sep; 9(9):. PubMed ID: 32899944
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Myocardial perfusion reserve quantified by cardiac magnetic resonance imaging is associated with late gadolinium enhancement in hypertrophic cardiomyopathy.
    Tezuka D; Kosuge H; Terashima M; Koyama N; Kishida T; Tada Y; Suzuki JI; Sasano T; Ashikaga T; Hirao K; Isobe M
    Heart Vessels; 2018 May; 33(5):513-520. PubMed ID: 29168014
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.